Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention
- PMID: 12573199
- DOI: 10.1007/s11883-003-0085-z
Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention
Abstract
Hypertension is the most widely treated cardiovascular risk factor, and there is clear evidence of the efficacy of treating systolic and diastolic blood pressure with existing antihypertensive agents in reducing stroke and cardiac disease. However, only about 25% of the US population has blood pressure controlled to at least 140 mm Hg systolic and 90 mm Hg diastolic. Hypertension control is a complex function of patient and physician behavior. Although poor hypertension control has historically been attributed to lack of health insurance or low utilization of available services, recently published analyses of national survey data and local physician and community samples suggest that physicians have a permissive attitude toward isolated mild systolic blood pressure elevations in the range of 140 to 160 mm Hg. The great majority of participants in health surveys report seeing a physician at least two times per year, and several investigators have documented that physicians are unlikely to increase treatment intensity for systolic elevations alone. Physician inaction toward elevated systolic blood pressure may be due to a reluctance to prescribe multiple drugs and/or lack of belief in the benefits of aggressive treatment to lower systolic blood pressure below 140 mm Hg.
Similar articles
-
Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.Hypertension. 2004 Jun;43(6):1338-44. doi: 10.1161/01.HYP.0000127424.59774.84. Epub 2004 Apr 26. Hypertension. 2004. PMID: 15117908
-
Poor hypertension control: let's stop blaming the patients.Cleve Clin J Med. 2002 Oct;69(10):793-9. doi: 10.3949/ccjm.69.10.793. Cleve Clin J Med. 2002. PMID: 12371802 Review.
-
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805. JAMA. 2003. PMID: 14657064 Clinical Trial.
-
Impact of hospitalization on blood pressure control in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).Pharmacotherapy. 2003 Feb;23(2):240-7. doi: 10.1592/phco.23.2.240.32087. Pharmacotherapy. 2003. PMID: 12587813
-
Prevalence and implications of uncontrolled systolic hypertension.Drugs Aging. 2003;20(4):277-86. doi: 10.2165/00002512-200320040-00004. Drugs Aging. 2003. PMID: 12641483 Review.
Cited by
-
A randomized community-based intervention trial comparing faith community nurse referrals to telephone-assisted physician appointments for health fair participants with elevated blood pressure.J Gen Intern Med. 2010 Jul;25(7):701-9. doi: 10.1007/s11606-010-1326-9. Epub 2010 Mar 27. J Gen Intern Med. 2010. PMID: 20349155 Free PMC article. Clinical Trial.
-
Impact of computerized decision support on blood pressure management and control: a randomized controlled trial.J Gen Intern Med. 2008 Apr;23(4):429-41. doi: 10.1007/s11606-007-0403-1. J Gen Intern Med. 2008. PMID: 18373141 Free PMC article. Clinical Trial.
-
Racial/ethnic disparity in the associations of smoking status with uncontrolled hypertension subtypes among hypertensive subjects.PLoS One. 2017 Aug 9;12(8):e0182807. doi: 10.1371/journal.pone.0182807. eCollection 2017. PLoS One. 2017. PMID: 28793323 Free PMC article.
-
Determinants of racial/ethnic differences in blood pressure management among hypertensive patients.BMC Cardiovasc Disord. 2005 Jun 22;5(1):16. doi: 10.1186/1471-2261-5-16. BMC Cardiovasc Disord. 2005. PMID: 15972095 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical